Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3

RVNC Stock  USD 3.04  0.01  0.33%   
About 68% of Revance's investor base is looking to short. The analysis of overall sentiment of trading Revance stock suggests that many investors are alarmed at this time. The current market sentiment, together with Revance's historical and current headlines, can help investors time the market. In addition, many technical investors use Revance stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Revance Officer: Cmo & Global Therapeutics Lead. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at thelincolnianonline.com
news
  
Revance insider trading alert for disposition of performance stock units by Hollander David, Officer: Cmo & Global Therapeutics Lead, on 27th of November 2024. This event was filed by Revance with SEC on 2025-02-15. Initial filing of beneficial ownership - SEC Form 3

Revance Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Revance can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Revance Fundamental Analysis

We analyze Revance's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revance using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revance based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Revance is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Revance Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Revance stock to make a market-neutral strategy. Peer analysis of Revance could also be used in its relative valuation, which is a method of valuing Revance by comparing valuation metrics with similar companies.

Peers

Revance Related Equities

ALVOAlvotech   1.86   
0%
20.0%
CTLTCatalent   1.61   
0%
18.0%
ITCIIntracellular   0.93   
0%
10.0%
TAKTakeda Pharmaceutical   0.74   
0%
8.0%
TEVATeva Pharma   0.58   
0%
6.0%
HLNHaleon Plc   0.31   
0%
3.0%
AMPHAmphastar   0.16   
1.0%
0%
EBSEmergent Biosolutions   0.46   
5.0%
0%
NBIXNeurocrine Biosciences   0.57   
6.0%
0%
BHCBausch Health   8.89   
100.0%
0%

Complementary Tools for Revance Stock analysis

When running Revance's price analysis, check to measure Revance's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revance is operating at the current time. Most of Revance's value examination focuses on studying past and present price action to predict the probability of Revance's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revance's price. Additionally, you may evaluate how the addition of Revance to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk